Active Ingredient: Haloperidol
Treatment of tic disorders, including Tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.
For this indication, competent medicine agencies globally authorize below treatments:
Oral
0.5 - 3 mg
From 0.167 To 1 mg 3 time(s) per day every day
0.5 mg
The need for continued treatment must be reassessed every 6 to 12 months.
The safety and efficacy of haloperidol oral solution 5 mg/5 ml in children below the ages defined in the indications have not been established. Data are not available for children aged less than 3 years.
Gradual withdrawal of haloperidol is advisable.
If patients miss a dose, it is recommended that they take the next dose as usual, and do not take a double dose.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
